HAb18G/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cells-Reference-Cited by-同舟云学术

HAb18G/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cells

Published:2011-12 Issue:6 Volume:54 Page:2012-2024
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Zhao Pu,Zhang Wei,Wang Shi-Jie,Yu Xiao-Ling,Tang Juan,Huang Wan,Li Yong,Cui Hong-Yong,Guo Yun-Shan,Tavernier Jan,Zhang Si-He,Jiang Jian-Li,Chen Zhi-Nan

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.24592/fullpdf

Reference47 articles.

1. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion;Wolf;Nat Cell Biol,2007

2. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis;Wolf;J Cell Biol,2003

3. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac;De Wever;FASEB J,2004

4. Transformation mediated by RhoA requires activity of ROCK kinases;Sahai;Curr Biol,1999

5. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis;Sahai;Nat Cell Biol,2003

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma;Molecular Cancer;2024-09-06

2. Alarmin S100A8 imparts chemoresistance of esophageal cancer by reprogramming cancer-associated fibroblasts;Cell Reports Medicine;2024-06

3. Hypoxia‐activated ADCC‐enhanced humanized anti‐CD147 antibody for liver cancer imaging and targeted therapy with improved selectivity;MedComm;2024-03

4. Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation;Molecular Pharmacology;2023-10-12

5. Migrasomes and tetraspanins in hepatocellular carcinoma: current status and future prospects;Future Science OA;2023-10